Skip to main content
Premium Trial:

Request an Annual Quote

Rudolph Potenzone, Victor Markowitz


Rudolph Potenzone has joined Ingenuity as senior vice president of business development and strategic planning. Potenzone was previously CEO of Lion Bioscience’s US subsidiary, Lion Bioscience Inc. He also worked at MDL as senior vice president for marketing and development, and held positions at Chemical Abstracts Service and Polygen/Molecular Simulations. Potenzone is also a co-founder of ChemTelligence Partners, an informatics consulting firm.

The US Department of Energy’s Joint Genome Institute has appointed Victor Markowitz to the newly created position of chief informatics officer. Markowitz also heads the recently established Biological Data Management and Technology Center within the Computational Research Division at Lawrence Berkeley National Laboratory. Prior to joining JGI, Markowitz served as CIO and senior vice president of data management systems at Gene Logic. Before that, he spent 10 years at LBNL.


Filed under

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.